ORIC Pharmaceuticals Inc (ORIC)
13.47
+0.01
(+0.07%)
USD |
NASDAQ |
Mar 28, 10:06
ORIC Pharmaceuticals Cash from Operations (TTM): -85.69M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -85.69M |
September 30, 2023 | -76.75M |
June 30, 2023 | -76.42M |
March 31, 2023 | -73.05M |
December 31, 2022 | -75.14M |
September 30, 2022 | -76.10M |
June 30, 2022 | -68.92M |
March 31, 2022 | -67.36M |
December 31, 2021 | -59.54M |
Date | Value |
---|---|
September 30, 2021 | -61.08M |
June 30, 2021 | -58.52M |
March 31, 2021 | -51.89M |
December 31, 2020 | -45.27M |
September 30, 2020 | -34.59M |
June 30, 2020 | -30.37M |
March 31, 2020 | -26.28M |
December 31, 2019 | -23.53M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-85.69M
Minimum
Dec 2023
-23.53M
Maximum
Dec 2019
-58.27M
Average
-61.08M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Geron Corp | -167.74M |
Verastem Inc | -86.46M |
Karyopharm Therapeutics Inc | -92.72M |
Blueprint Medicines Corp | -436.85M |
Syndax Pharmaceuticals Inc | -160.60M |